New hope for kids with Hard-to-Treat tumors: radioactive therapy trial opens
Disease control
Recruiting now
This early-stage trial tests a radioactive drug (Lu-177 edotreotide) in children aged 2 to 17 with tumors that have a specific marker (SSTR-positive). The goal is to find the right dose and check safety. About 20 children whose cancer has returned or not responded to prior treatm…
Phase: PHASE1 • Sponsor: ITM Solucin GmbH • Aim: Disease control
Last updated Apr 28, 2026 13:02 UTC